FDA Inspection 1004795 — Madappa Kundranda, MD, PhD

Madappa Kundranda, MD, PhD — FEI 3013145128

The FDA completed an inspection of Madappa Kundranda, MD, PhD on Mar 13, 2017 in Gilbert, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 13, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Gilbert, AZ (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance